Researchers have scored the first big win against melanoma, the deadliest form of skin cancer. An experimental drug significantly improved survival in a major study of people with very advanced disease.
The results, reported Saturday at a cancer conference, left doctors elated.
“We have not had any therapy that has prolonged survival” until now, said Dr. Lynn Schuchter, a skin cancer specialist with no role in the study or ties to the drug’s maker.
(READ more at the San Francisco Examiner)